Genesis Biotechnology Group CEO and leadership

Dr. Adelson joined the GBG team in 2002. As the Chief Operating Officer, Dr. Adelson leads clinical, development, and discovery research operations in Medical Diagnostic Laboratories, L.L.C. (MDL), Venenum Biodesign, LLC, and Invivotek LLC, with his main focus concentrating on scaling and expanding the existing business infrastructure through both organic growth and corporate acquisition. In addition, Dr. Adelson implements various innovations and re-engineering initiatives, as well as leverages customized technology solutions, to re-calibrate and enhance MDL's work flow while reducing overall business costs.

Prior to his appointment to Chief Operating Officer in 2013, Dr. Adelson held positions within MDL as Director of Research & Development before becoming Vice President of MDL in 2007.

Dr. Adelson received his BS in Biology from The College of New Jersey (formerly Trenton State College) in Ewing, NJ. He earned his Ph.D. in Molecular Biology & Genetics from the Department of Molecular Biology and Genetics/Fels Institute for Molecular Biology and Cancer at Temple University School of Medicine in Philadelphia, PA. He completed his postdoctoral studies in the Department of Microbiology and Molecular Genetics at the University of Medicine and Dentistry of New Jersey. Dr. Adleson was the proud recipient of a competitive Postdoctoral Research Fellowship from the National Institutes of Health, National Lung, and Blood Institute.

Joe joined the GBG team in 2007 as the Accounting Manager. As the Chief Financial Officer since 2011, he is responsible for the accounting and finance functions of all GBG member companies. Joe manages the Accounting Department staff as well as day-to-day operations regarding all cash balances and the maintenance of our internal financial software. He is responsible for establishing and maintaining all banking relationships including financial reporting to banks and third party investors. He provides leadership and strategy development for financial and tax initiatives and is a vital member of the Merger and Acquisition team.

Prior to joining GBG, Joe brought with him twenty years of experience in the financial side of the manufacturing, retail, and distribution industries. Joe previously held positions as Controller of Omnitester Corp as well as Assistant Controller and Credit Manager for The Camera Shop, Inc.

Joe received his BA in Accounting from St. Joseph’s University in Philadelphia, PA.

Stephanie Berry is a Chief Human Resources Officer at GENESIS BIOTECHNOLOGY GROUP.

Stephanie joined the GBG team in 1999. As the Chief Marketing Officer, she provides leadership for the Marketing Department members including the graphic design team. She is responsible for developing, implementing, and maintaining the marketing efforts and supportive collateral for new and existing product lines and services for all GBG Member companies across all lines of business. Stephanie was directly involved in the implementation and supervision of modified processes in the sales and client daily and standing supply order process which streamlined work flow while reducing overall associated business costs.

Stephanie joined Medical Diagnostic Laboratories, L.L.C. (MDL) as a Laboratory Technician in 1999 and has since held various management positions of increasing responsibility. She developed the Quality Control Department for which she became the Quality Control Manager in 2000. As the division continued to grow in both scope and size, in 2004 Stephanie became the Director of Quality Assurance & Quality Control. In 2007, she transitioned into the role of Director of Marketing. Stephanie held a dual Directorship for ten years where she also served as the Director of Administration from 2005 - 2015. In 2021, Stephanie assumed her current role of Chief Marketing Officer.

Prior to GBG, Stephanie held a position as a Professional Blood Bank Technologist in the Department of Laboratory Medicine and Transfusion Services at the University of Pennsylvania Hospital in Philadelphia, Pennsylvania.

Stephanie received a BS in Medical Technology from the University of Delaware in Newark, De. She is a board certified Medical Technologist with the American Society of Clinical Pathologists (ASCP).

Susan joined the GBG team in 2011. As the Chief Legal Officer, Susan provides advice and leadership to the GBG family of companies to enhance its position in the fields of clinical diagnostics, drug discovery, product development, manufacturing, and distribution. In addition, Susan structures the transactions for mergers and acquisitions to assist GBG with its strategic growth initiatives in addition to managing a staff of attorneys and outside counsel to address challenges and litigation in the areas of corporate, regulatory, compliance, healthcare, intellectual property, contracts, and employment law.

Prior to her appointment to Chief Legal Officer in 2017, Susan held positions within GBG as Associate Regulatory Counsel 2011-2015, Associate General Counsel 2015-2016, and Deputy General Counsel 2016-2017.

Susan brought twenty five years of Legal experience to the GBG Team through her previous position State of New Jersey Officer of the Attorney General where she served as the Deputy Attorney General.

Susan received her BA & BS in Arts and Science from Pennsylvania State University in State College, PA. She earned her Juris Doctor from Widener University School of Law in Wilmington, DE.

Susan was proud recipient of many awards during her time in the Office of the Attorney General Awards including Excellence in Management 2009, Excellence in Investigations 2009, and Excellence in Trial Litigation 2008. Susan was also awarded with a 2014 Galaxy Award at GBG.

Successful professional with broad expertise and years of experience in biomedical research in industrial and academic settings. Demonstrated leadership skills and ability to carry out challenging projects to successful completion. Built and managed a multidisciplinary research group that was recently acclaimed as the best contract research group for in vivo phenotyping in North America. Established and managed successful collaborations with pharmaceutical and biotech partners in several disease areas including immunological CNS and metabolic disease and oncology. Knowledgeable in many in vivo and in vitro technologies utilized in pre-clinical translational research. Experienced in evaluation of products and technologies for in-licensing opportunities.

Stephanie Berry is a Chief Human Resources Officer at GENESIS BIOTECHNOLOGY GROUP.

Stephanie joined the GBG team in 1999. As the Chief Marketing Officer, she provides leadership for the Marketing Department members including the graphic design team. She is responsible for developing, implementing, and maintaining the marketing efforts and supportive collateral for new and existing product lines and services for all GBG Member companies across all lines of business. Stephanie was directly involved in the implementation and supervision of modified processes in the sales and client daily and standing supply order process which streamlined work flow while reducing overall associated business costs.

Stephanie joined Medical Diagnostic Laboratories, L.L.C. (MDL) as a Laboratory Technician in 1999 and has since held various management positions of increasing responsibility. She developed the Quality Control Department for which she became the Quality Control Manager in 2000. As the division continued to grow in both scope and size, in 2004 Stephanie became the Director of Quality Assurance & Quality Control. In 2007, she transitioned into the role of Director of Marketing. Stephanie held a dual Directorship for ten years where she also served as the Director of Administration from 2005 - 2015. In 2021, Stephanie assumed her current role of Chief Marketing Officer.

Prior to GBG, Stephanie held a position as a Professional Blood Bank Technologist in the Department of Laboratory Medicine and Transfusion Services at the University of Pennsylvania Hospital in Philadelphia, Pennsylvania.

Stephanie received a BS in Medical Technology from the University of Delaware in Newark, De. She is a board certified Medical Technologist with the American Society of Clinical Pathologists (ASCP).